Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

May 6, 2025

Dr. Skupsky details how dermatologists can use ancillary testing to guide their decision making on atypical pigmented lesions.

MORE EXPERT PERSPECTIVES IN MELANOMA:

Jason Rizzo, MD, PhD: Evaluating Melanoma-specific Survival Stratification and Survival Benefit of Gene Testing in Patients with Melanoma

Brent Moody, MD: Assessing the Prognostic Significance of the 31-gene Expression Profile Test

Jason Rizzo, MD: Utility of Gene Expression Profile Testing for Prognosis in Cutaneous Melanoma

Abel Jarell, MD, FAAD: Identifying the Risk of Central Nervous System Metastasis Using the 31-Gene Expression Profile Test

©2026 Oncology Matrix. All Rights Reserved.